José Roberto Trujillo is a Mexican American Physician and Scientist, in the field of neuroscience and molecular virology. He is the Founder, Chairman, and CEO of NeuroCytonix. Inc., a cutting-edge biomedical technology company focused on tissue engineering and regeneration of the nervous system.
Trujillo obtained his Doctor of Science degree in Neurosciences and Molecular Virology at Harvard University in 1995. He was the first doctoral student at Harvard University to combine the studies of neuroscience and virology and is well known as a pioneer in molecular neurovirology at Harvard. Dr. Trujillo established the Pan-American Society of Neurovirology in the year 2000 as an effort to bring together scientists across the Americas, especially Latin America, to understand the impact of viral infections on the nervous system.
As a solution-driven scientist, Trujillo is constantly drawn to the latest research and advancements in biomedical technology. Over the years he has collaborated with well-known scientists to find solutions to diseases through biomedical innovations. In 2012, he co-created CerCa, a photodynamic therapeutic medical device that can help treat the human papillomavirus (HPV) and prevent cervical cancer. Dr. Trujillo’s current focus is on translational neural tissue engineering for the treatment of neurological disorders such as cerebral palsy, stroke, traumatic brain injuries, and neurologic complications caused by viral infections. The company, NeuroCytonix, was established by him in 2017 to offer innovative biomedical technology for incurable neurological diseases.
Over the course of 30 years, Dr. Trujillo has been on various scientific editorial boards and has published more than 60 scientific manuscripts and reviews in neurosciences and molecular virology. He has held academic posts at prestigious institutions such as Harvard University, the National Institute of Neurological Disorders and Stroke (NIH), and the University of Maryland.
Since 2010, he has founded and raised support for several biotech companies in the biotechnological corridor of the state of Maryland and Latin American markets. Dr. Trujillo has received several awards and honors for his services to science and society. His work continues to inspire and impress people. He is a leader who wishes to relentlessly contribute to areas of research, biomedical technology, and societal welfare.
